To find out more about PASA and our ongoing clinical trials and studies, please contact the following:
Study: Kappa Opioid Receptor Antagonism for the Treatment of Alcohol Use Disorder and Comorbid PTSD
Tuscaloosa and Birmingham VA Medical Centers (Tuscaloosa and Birmingham, AL)
Lori Davis, MD
Associate Chief of Staff for Research and Development
Email: lori.davis@va.gov
West Haven VA Medical Center (West Haven, CT)
Ismene Petrakis, MD
Chief of Mental Health Service Line, VACT Healthcare
Email: ismene.petrakis@yale.edu
Wayne State University (Detroit, MI)
Seth Norrholm, PhD
Associate Professor in Psychiatry and Behavioral Neurosciences
Scientific Director, Neuroscience Center for Anxiety, Stress, and Trauma
Email: SNorrholm@wayne.edu
Study: Lofexidine Combined with Buprenorphine for Reducing Symptoms of Post-Traumatic Stress Disorder and Opioid Use Relapse in Veterans
Baylor College of Medicine / Michael E. DeBakey VA Medical Center (Houston, TX)
Christopher D. Verrico, PhD
Assistant Professor of Psychiatry
Email: verrico@bcm.edu
Study: Preclinical Testing of FKBP5 Inhibitors for Alcohol Use Disorder-PTSD Comorbidity
The Scripps Research Institute (La Jolla, CA)
Marisa Roberto
Professor, Molecular Medicine Department
Email: mroberto@scripps.edu
Study: Novel Strategies for the Treatment of Opioid Use Disorder and Post-Traumatic Stress Disorder: Anti-Fentanyl Vaccine and Buprenorphine Combination Therapy
University of Houston (Houston, TX)
Colin N. Haile, MD, PhD
Research Associate Professor, Director of Operations, UH Animal Behavior Core Facility
Email: cnhaile@Central.UH.EDU
Study: Preclinical assessment of PT-150 for opioid use disorder and PTSD
University of Kentucky (Lexington, KY)
Michael Bardo, PhD
Research Professor, Department of Psychology
Email: mbardo@uky.edu
Study: Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517)
Baylor College of Medicine / Michael E. DeBakey VA Medical Center (Houston, TX)
Christopher D. Verrico, PhD
Assistant Professor of Psychiatry
Email: verrico@bcm.edu
Study: Leveraging multi-omic data integration for in silico compound prioritization
RTI International, GenOmics, Bioinformatics & Translational Research Center (Research Triangle Park, NC)
Bradley Todd Webb, Ph.D.
Omics Research Scientist, Principal Investigator
Email: bwebb@rti.org
Study: An Aldehyde Dehydrogenase 2 Inhibitor, ANS-6637, for Reducing Symptoms of Post-Traumatic Stress Disorder and Alcohol Use Disorder in Veterans
University of Texas Health Science Center at Houston, McGovern Medical School (Houston, TX)
Luba Yammine , PhD, APRN, FNP-C
Associate Professor of Psychiatry and Behavioral Sciences
Email: Luba.Yammine@uth.tmc.edu
PASA Consortium Leadership
RTI International (Data Coordinating Center) (Research Triangle Park, NC)
Tracy Nolen, DrPh
Project Director and Principal Investigator
Email: tnolen@rti.org
Nathan Vandergrift, PhD
Co-Principal Investigator
Email: nvandergrift@rti.org
Amy Kendrick
PASA Clinical Research Manager
Email: akendrick@rti.org
Baylor College of Medicine (Houston, TX)
Thomas Kosten, MD
Division of Alcohol and Addiction Psychiatry
E-mail: Kosten@bcm.edu